[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Item 1 of about 1
1. Vanderhelst E, De Keukeleire T, Verbanck S, Vincken W, Noppen M: Quality of life and patient satisfaction after video-assisted thoracic sympathicolysis for essential hyperhidrosis: a follow-up of 138 patients. J Laparoendosc Adv Surg Tech A; 2011 Dec;21(10):905-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quality of life and patient satisfaction after video-assisted thoracic sympathicolysis for essential hyperhidrosis: a follow-up of 138 patients.
  • OBJECTIVES: Essential hyperhidrosis (EH) is defined as excessive functioning of the sudomotor sweat system.
  • Definitive treatment of choice is video-assisted thoracoscopic sympathetic interruption.
  • Success rates are high, but compensatory hyperhidrosis (CH) remains a troublesome side effect.
  • The aim of this study was to document patient satisfaction and side effects at least 6 months after thoracoscopic sympathicolysis.
  • METHODS: Between 2001 and 2005, 246 patients underwent bilateral ablation of the sympathetic chain at the thoracic level T2, T3, and/or T4.
  • Questionnaires using open questions and scoring systems were sent at least 6 months after procedure and were returned by 138 patients (56%).
  • RESULTS: From the 138 patients (56 males/82 females), 39 suffered from cranial (±facial blushing), 34 from palmar, and 34 from axillary hyperhidrosis.
  • Thirty-one patients were treated for a combination.
  • No conversion to open surgery or deaths occurred.
  • For the whole group, average quality of life was 4.5±2.5 before and 8.4±1.8 after surgery (P<.001).
  • Ninety-one percent were very satisfied (score ≥7) and 80% showed an increased quality of life of ≥2.
  • Compensatory sweating occurred in 76% of the patients, only 6% reported this as disabling.
  • Comparing subgroups, a significant improvement in primary complaint score was found in 90%, 94%, and 91% for the T2, T3, and T4 patients, respectively.
  • In the T4 group, the prevalence of CH was markedly lower (53%) and none of these patients were dissatisfied.
  • CONCLUSION: Thoracoscopic ablation of the sympathetic chain is an effective treatment for EH; CH occurs in the majority of patients, but only rarely impairs postoperative quality of life.
  • [MeSH-major] Hyperhidrosis / surgery. Patient Satisfaction. Quality of Life. Sympathectomy / methods. Thoracic Surgery, Video-Assisted
  • [MeSH-minor] Adult. Female. Follow-Up Studies. Humans. Male. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22011277.001).
  • [ISSN] 1557-9034
  • [Journal-full-title] Journal of laparoendoscopic & advanced surgical techniques. Part A
  • [ISO-abbreviation] J Laparoendosc Adv Surg Tech A
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement





Advertisement